Table 6.
Association between disease severity of COVID-19 and laboratory characteristics by multiple regression analysis
Variable | Mild cases (n = 81) |
Ordinary cases (n = 486) |
Severe and critical cases (n = 31) |
|||
---|---|---|---|---|---|---|
OR(95%CI) | P value | OR(95%CI) | P value | OR(95%CI) | P value | |
Platelet count (×109/L) (n = 474) |
0.997(0.992–1.002) | 0.199 | 0.991(0.986–0.995) | < 0.001 | 0.979(0.969–0.989) | < 0.001 |
White blood cell count (×109/L) (n = 503) |
0.923(0.779–1.093) | 0.351 | 0.755(0.649–0.879) | < 0.001 | 0.913(0.725–1.149) | 0.437 |
Lymphocyte count (×109/L) (n = 491) |
0.794(0.564–1.118) | 0.187 | 0.383(0.259–0.567) | < 0.001 | 0.029(0.007–0.114) | < 0.001 |
Potassium (mmol/L) (n = 418) |
0.685(0.351–1.336) | 0.267 | 1.010(0.836–1.221) | 0.917 | 0.283(0.097–0.830) | 0.021 |
Albumin (g/L) (n = 462) |
0.953(0.877–1.036) | 0.258 | 0.881(0.820–0.947) | 0.001 | 0.837(0.754–0.930) | 0.001 |
Aspartate aminotransferase (U/L) (n = 390) |
0.987(0.933–1.045) | 0.657 | 1.045(1.000–1.093) | 0.052 | 1.071(1.021–1.124) | 0.005 |
Alanine aminotransferase (U/L) (n = 464) |
1.008(0.983–1.034) | 0.517 | 1.018(0.996–1.040) | 0.109 | 1.031(1.004–1.058) | 0.024 |
Fibrinogen (g/L) (n = 529) |
1.512(0.929–2.460) | 0.096 | 2.514(1.661–3.888) | < 0.001 | 3.597(2.171–5.960) | < 0.001 |
Erythrocyte sedimentation rate (mm/h) (n = 326) | 1.044(1.005–1.085) | 0.028 | 1.047(1.011–1.084) | 0.009 | 1.086(1.044–1.129) | < 0.001 |
C-reactive protein (mg/L) (n = 486) |
0.882(0.305–2.549) | 0.817 | 0.246(0.103–0.585) | 0.002 | 0.042(0.010–0.186) | < 0.001 |
CD3 + T lymphocytes (/ul) (n = 123) |
1.000(0.999–1.001) | 0.777 | 0.999(0.998–1.000) | 0.040 | 0.995(0.990–0.999) | 0.024 |
CD4 + T lymphocytes (/ul) (n = 123) |
0.999(0.997–1.001) | 0.382 | 0.998(0.997–1.000) | 0.050 | 0.994(0.987–1.000) | 0.042 |
CD8 + T lymphocytes (/ul) (n = 123) |
1.000(0.998–1.003) | 0.717 | 0.999(0.996–1.001) | 0.215 | 0.998(0.976–1.000) | 0.047 |
CD: cluster of differentiation; OR: odds ratio; CI: confidence interval.